Tarsus Pharmaceuticals (NASDAQ: TARS) insider files to sell 12,500 shares

Rhea-AI Filing Summary

Tarsus Pharmaceuticals, Inc. filed a Form 144 notifying a proposed sale of 12,500 shares of Common Stock by William J. Link. The shares are identified as from a Stock Option Exercise dated 01/10/2017 and the method of sale is listed as Cash.

The filing also lists a sale of 12,500 shares on 03/16/2026 with proceeds of $859,787.14.

Insights

Corporate Governance Analyst

Routine Form 144 notice: insider proposes resale of option‑derived shares.

Form 144 filings are administrative notices that report an affiliate’s intent to sell restricted or control shares under applicable resale exemptions. This filing records 12,500 shares tied to a Stock Option Exercise dated 01/10/2017.

Cash proceeds treatment is stated; a prior sale of 12,500 shares on 03/16/2026 for $859,787.14 is also shown. Timing and execution details of any resale are not provided in the excerpt.

Key Figures

Shares offered (Form 144): 12,500 shares Proceeds reported (prior sale): $859,787.14 Option exercise date: 01/10/2017 +1 more

4 metrics

Shares offered (Form 144) 12,500 shares Securities To Be Sold entry (Stock Option Exercise)

Proceeds reported (prior sale) $859,787.14 Securities Sold During The Past 3 Months on <date>03/16/2026</date>

Option exercise date 01/10/2017 Listed next to Stock Option Exercise

Prior sale date 03/16/2026 Securities Sold During The Past 3 Months

Key Terms

Form 144, Stock Option Exercise, Securities Sold During The Past 3 Months

3 terms

Form 144 regulatory

"Filer Information | 144: Filer Information"

Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.

Stock Option Exercise financial

"Securities To Be Sold | Stock Option Exercise"

A stock option exercise is the act of using a previously granted right to buy shares of a company's stock at a specific, predetermined price by paying that price and receiving the shares. It matters to investors because exercising changes who owns the shares (which can dilute existing ownership), can trigger taxable events and shift potential gains or losses, and affects voting power and the company’s outstanding share count—like turning a voucher into an actual product that becomes part of circulating supply.

Securities Sold During The Past 3 Months regulatory

"Securities Sold During The Past 3 Months | 03/16/2026"

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Merrill Lynch 520 Newport Center Drive 20th Floor Newport Beach CA 92660	12500	776497.54	43023959	06/15/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	01/10/2017	Stock Option Exercise	Tarsus Pharmaceuticals, Inc.			12500	01/10/2017	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
William J Link 17700 Laguna Canyon Road Floor 4 Irvine CA 92618	Common	03/16/2026	12500	859787.14

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What did TARS disclose in this Form 144 filing?

The filing notifies a proposed sale of 12,500 common shares by William J. Link, linked to a Stock Option Exercise dated 01/10/2017. It lists the sale method as Cash.

Who is the selling party in the Form 144 for TARS?

The seller named is William J. Link, with an address listed in Irvine, CA. The filing attributes the shares to an earlier Stock Option Exercise dated 01/10/2017.

Does the filing show recent sales of TARS shares by the same party?

Yes. The filing lists a sale on 03/16/2026 of 12,500 shares with reported proceeds of $859,787.14. The excerpt presents that prior sale as a disclosed item.

Does this Form 144 state when the proposed shares will be sold?

No specific sale date or execution timeline is provided in the excerpt. The filing lists the shares and method as Cash, but does not disclose the timing of resale.